6zss
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='6zss' size='340' side='right'caption='[[6zss]]' scene=''> | <StructureSection load='6zss' size='340' side='right'caption='[[6zss]]' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'> | + | <table><tr><td colspan='2'>Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6ZSS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6ZSS FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6zss FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6zss OCA], [https://pdbe.org/6zss PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6zss RCSB], [https://www.ebi.ac.uk/pdbsum/6zss PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6zss ProSAT]</span></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6zss FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6zss OCA], [https://pdbe.org/6zss PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6zss RCSB], [https://www.ebi.ac.uk/pdbsum/6zss PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6zss ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| - | == Function == | ||
| - | [https://www.uniprot.org/uniprot/LYPD1_HUMAN LYPD1_HUMAN] Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro increases receptor desensitization and decreases affinity for ACh of alpha-4:beta-2-containing nAChRs. May play a role in the intracellular trafficking of alpha-4:beta-2 and alpha-7-containing nAChRs and may inhibit their expression at the cell surface. May be involved in the control of anxiety.[UniProtKB:Q8BLC3] | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 21: | Line 20: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Kocharovskaya MV]] | [[Category: Kocharovskaya MV]] | ||
Current revision
NMR structure of water-soluble domain of human Lynx2 (Lypd1) protein
| |||||||||||
